Brain Tumor Treatments: Massachusetts

Major Brain Tumor Centers

(This is not a complete listing - see this page for details)


		MA: Boston		Beth Israel Deaconess Medical Center

		MA: Boston		Boston University

		MA: Boston		Brigham & Womans Hospital & Childrens Hospital

		MA: Boston		Cancer Research Center at Boston Medical Center

		MA: boston		Children`s Hospital

		MA: Boston ,		Dana-Farber Cancer Institute

		MA: Boston		Dana-Farber/Harvard Cancer Center

		MA: Boston		Mass. General Hospital - Brain Tumor Center

		MA: Boston		Massachusetts General Hospital

		MA: Boston		Massachusetts General Hospital Cancer Center

		MA: Boston		Tufts Medical Center

		MA: Burlington		Lahey Clinic

		MA: Burlington		Lahey Clinic Medical Center

		MA: Cambridge		Massachusetts Institute of Technology

		MA: Worcester		U. Of Mass. Memorial Healthcare

		MA: Worcester		U. of Massachusetts Medical - Dept of Radiation Oncology

		MA: Worcester		UMASS Memorial Cancer Center - University Campus

		MA: Worcester		Univ. of Mass. Medical School

Search Term: Massachusetts


	Showing Treatment 1 to 25 of 26	Location	Last Updated

Details	Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III)	Boston, MA	03/09/2010

Details	Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)	Chicago, IL	11/30/2009

Details	Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor	Boston, MA	09/06/2009

Details	Gliogene: An International Brain Tumor Study	Houston, TX	07/24/2008

Details	Phase I/II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme	Houston , TX	04/27/2008

Details	A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas	Boston, MA	04/15/2008

Details	Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma	Cleveland, OH	04/11/2008

Details	NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma	Boston, MA	10/03/2007

Details	Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma	Boston, MA	08/19/2007

Details	A Pilot Multicenter Phase I/II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme	Boston, MA	08/19/2007

Details	Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma	Boston, MA	08/04/2007

Details	A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas	Cleveland, OH	05/01/2007

Details	Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer	Cleveland, OH	05/01/2007

Details	Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma	Boston, MA	05/01/2007

Details	PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas	Boston, MA	05/04/2006

Details	The use of the Gliasite radiation therapy system for malignant gliomas	Mobile , AL	12/03/2005

Details	Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma	,	11/27/2005

Details	A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas	Boston, MA	11/27/2005

Details	A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma	Chicago, IL	11/13/2005

Details	Study of Lenalidomide and XRT in Patients with Newly Diagnosed Glioblastoma Multiforme	Boston, MA	11/09/2005

Details	Phase I Study of Tipifarnib and Radiotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma	Boston, MA	11/06/2005

Details	A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy	Mobile, AL	11/06/2005

Details	SWOG (RTOG) 98-13 randomized trial of RT + Temozolomide vs RT + BCNU, versus RT+ Tem + BCNU	Mobile , AL	11/06/2005

Details	Z0300: Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in the Management of Patients with One to Three Cerebral Mets	Mobile , AL	11/06/2005

Details	Radiosurgery with the Varian Trilogy system for benign or malignant brain tumors	Mobile , AL	11/06/2005

Articles on this website which contain the search term:

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2010 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By